Drug Shortage Report for CYSTADANE
| Report ID | 274961 |
| Drug Identification Number | 02238526 |
| Brand name | CYSTADANE |
| Common or Proper name | CYSTADANE |
| Company Name | RECORDATI RARE DISEASES CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BETAINE |
| Strength(s) | 1G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | 180 g in Bottle |
| ATC code | A16AA |
| ATC description | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-03-02 |
| Actual start date | |
| Estimated end date | 2026-06-30 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-12-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3080 YONGE STREET, SUITE 6060 TORONTO, ONTARIO CANADA M4N 3N1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-12-23 | French | Compare |
| v2 | 2025-12-23 | English | Compare |
| v1 | 2025-12-23 | English | Compare |
Showing 1 to 3 of 3